IRIS
TOSCANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.736
EU - Europa 18.423
AS - Asia 11.220
SA - Sud America 3.774
Continente sconosciuto - Info sul continente non disponibili 983
AF - Africa 316
OC - Oceania 13
Totale 53.465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.293
RU - Federazione Russa 9.657
SG - Singapore 4.719
BR - Brasile 3.197
CN - Cina 3.157
IE - Irlanda 2.406
SE - Svezia 1.614
HK - Hong Kong 1.259
IT - Italia 1.246
DE - Germania 771
VN - Vietnam 616
FR - Francia 559
UA - Ucraina 531
FI - Finlandia 470
PL - Polonia 381
IN - India 337
GB - Regno Unito 313
BD - Bangladesh 200
AR - Argentina 185
CA - Canada 182
MX - Messico 119
TR - Turchia 108
NL - Olanda 105
EC - Ecuador 98
ID - Indonesia 97
ZA - Sudafrica 93
IQ - Iraq 87
JP - Giappone 86
CO - Colombia 79
BE - Belgio 76
AT - Austria 73
PK - Pakistan 69
VE - Venezuela 66
MA - Marocco 56
UZ - Uzbekistan 55
TH - Thailandia 54
PY - Paraguay 51
ES - Italia 48
CL - Cile 39
KE - Kenya 34
TN - Tunisia 32
PH - Filippine 30
JO - Giordania 29
MY - Malesia 29
PE - Perù 29
JM - Giamaica 28
KZ - Kazakistan 27
LT - Lituania 27
IR - Iran 26
SA - Arabia Saudita 26
AE - Emirati Arabi Uniti 25
IL - Israele 24
AZ - Azerbaigian 23
CI - Costa d'Avorio 23
CZ - Repubblica Ceca 23
EG - Egitto 20
DZ - Algeria 19
HN - Honduras 19
NP - Nepal 19
OM - Oman 18
DO - Repubblica Dominicana 17
LB - Libano 17
UY - Uruguay 16
CR - Costa Rica 15
AL - Albania 13
GT - Guatemala 13
HR - Croazia 13
BO - Bolivia 12
KR - Corea 12
KG - Kirghizistan 11
RS - Serbia 11
RO - Romania 10
PA - Panama 9
PT - Portogallo 9
AU - Australia 8
CH - Svizzera 8
BG - Bulgaria 7
ET - Etiopia 7
GR - Grecia 7
PS - Palestinian Territory 7
SN - Senegal 7
TT - Trinidad e Tobago 7
AM - Armenia 6
BA - Bosnia-Erzegovina 6
DK - Danimarca 6
EU - Europa 6
LV - Lettonia 6
NI - Nicaragua 6
PR - Porto Rico 6
QA - Qatar 6
AO - Angola 5
BY - Bielorussia 5
GA - Gabon 5
HU - Ungheria 5
KW - Kuwait 5
LK - Sri Lanka 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
BZ - Belize 4
KH - Cambogia 4
Totale 52.413
Salva come PNG Salva come JPEG
Città #
Moscow 3.037
Ashburn 2.696
Dublin 2.404
Singapore 2.265
Dallas 2.164
Chandler 1.487
Hong Kong 1.259
Jacksonville 1.154
Nyköping 1.027
Beijing 971
San Jose 865
Council Bluffs 715
The Dalles 559
Princeton 441
Los Angeles 431
Medford 407
Messina 398
Lauterbourg 385
Warsaw 368
Cambridge 334
Des Moines 317
Dearborn 308
Ann Arbor 286
New York 284
São Paulo 241
Ho Chi Minh City 200
Buffalo 199
Munich 175
Santa Clara 150
Wilmington 149
Tianjin 146
Boardman 140
Hanoi 119
Guangzhou 118
Jinan 117
San Mateo 113
Shenyang 108
Orem 107
Redondo Beach 104
Frankfurt am Main 99
Rio de Janeiro 94
Rome 86
Nanjing 83
Belo Horizonte 79
Houston 77
Atlanta 75
Tokyo 75
Brooklyn 74
Hyderabad 71
Turku 71
Ningbo 67
Chennai 64
Helsinki 61
Phoenix 60
Brasília 58
Nuremberg 57
San Francisco 57
Zhengzhou 57
Denver 56
Columbus 55
Woodbridge 54
Hebei 52
Brussels 51
Milan 51
Bremen 50
Curitiba 49
Johannesburg 49
Seattle 49
Chicago 48
Shanghai 48
Shenzhen 48
Amsterdam 47
Hangzhou 47
Tashkent 47
Falls Church 42
Jakarta 42
Pune 42
Vienna 42
Bangkok 41
Montreal 41
Campinas 40
Taizhou 40
Guayaquil 38
Lancaster 38
London 38
Mexico City 37
Catania 36
Dong Ket 36
Porto Alegre 36
Stockholm 35
Boston 34
Toronto 34
Haikou 32
Mumbai 32
Nairobi 32
Quito 32
Salvador 32
Ankara 29
Fortaleza 29
Fuzhou 29
Totale 29.853
Salva come PNG Salva come JPEG
Nome #
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 684
The relationship between sleep quality and ratio of house size/number of people in chronic migraineurs during Covid-19 lockdown. 308
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 288
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 268
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 259
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 256
Ischemic stroke and reperfusion therapies in diabetic patients 254
Clinical and pathological features of focal myositis 252
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 251
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 225
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 218
Atypical posterior reversible encephalopathy syndrome with hemispheric brainstem and spinal cord involvement in a patient with acute kidney injury – a case report. 217
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 215
A cytochemical study of apoptosis in metabolic myopathies 214
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 213
A life threatening case of β-enolase deficiency 205
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 201
Dolori muscolari, deficit di forza e/o disturbi sensitivi 200
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 200
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 198
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 198
A decreased muscle content of HPRG correlates with the reduction of AMP deaminase activity observed in patients affected by myoadenylate deficiencies 196
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 195
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 194
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 194
Community-acquired enterococcal meningitis caused by Enterococcus casseliflavus: first case report 193
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 193
Auditory system involvement study in 20 patients with late-onset Pompe disease 189
Pimozide and pancreatic cancer in diabetic chorea: a case report 188
Variants of the circle of Willis in ischemic stroke patients 185
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism. 183
A case of vacuolar myopathy during the course of chronic hepatitis C. 182
A benign case of congenital myotonic dystrophy 182
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 182
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 182
Sleep and sleep‐modifying factors in chronic migraine patients during the COVID‐19 lockdown 181
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 180
ANT1 is reduced in sporadic inclusion body myositis. 180
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 180
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 179
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 178
Low-carbohydrate ketogenic diet in Mc Ardle's disease: a single-blinded randomized controlled trial 177
Analysis of lipid profile in lipid storage myopathy 177
Isolated Insular Stroke: Clinical Presentation 176
A genetic modifier of symptom onset in Pompe disease 175
Enterococcal meningitis caused by Enterococcus casseliflavus. First case report. 173
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 173
A study of auditory system in 20 patients with late onset Pompe disease 172
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 171
A novel Cx32 mutation with unusual phenotype. 171
211th ENMC International Workshop:: Development of diagnostic criteria and management strategies for McArdle Disease and related rare glycogenolytic disorders to improve standards of care. 17–19 April 2015, Naarden, The Netherlands 171
Apoptosis and apoptosis-related proteins in thyroid myopathies 170
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 169
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 168
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 168
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 168
Management of Teenage Stroke in the Acute Setting: Two Case Reports 168
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 167
Autoimmune juvenile limb-girdle myasthenia 166
Acute ischemic stroke due to endocarditis from Brucella infection 163
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 162
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 161
Deficit multiplo di Acyl-CoA deidrogenasi responsivo alla riboflavina (MADD-RR): studio clinico, biochimico, genetico e spettroscopico 160
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 160
A novel mithocondrial tRNAHys point mutation in a patient with PSP-like phenotype. 160
Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection. 160
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 160
Auditory system involvement study in 20 patients with lateonset pompe disease 159
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 159
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 159
Chronic migraine in the first COVID‐19 lockdown: the impact of sleep, remote working, and other life/psychological changes 159
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 158
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 158
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 158
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 158
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 157
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 157
Primary CNS infiltrative parenchymal histiocytosis 157
Dolori muscolari, deficit di forza e/o disturbi sensitivi 156
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07) 154
208th ENMC International Workshop: Formation of a European Network to develop a European data sharing model and treatment guidelines for Pompe disease. 154
Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum 154
Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene 153
Fatal R631C mutation is also present in the adult form of CPTII deficiency 152
Severe rhabdomyolysis in a patient with “Heat Stroke” 152
Repeated reperfusion treatment in recurrent ischemic stroke: A retrospective single-center case series 152
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 151
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 150
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 150
Miopatie metaboliche 150
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 150
MuSK-Associated Myasthenia Gravis: Clinical Features and Management 150
Recurrent intracranial hemorrhage and cerebral venous sinus thrombosis: an atypical case of Neuro-Behçet’s Syndrome 150
Facioscapulohumeral Muscular Dystrophy and Poliomyelitis followed by Multiple Sclerosis: A “triple trouble” case report and review of the literature on the association of MS and muscle disorders 150
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation 149
Minor stroke with bilateral acute infarctions and combined vascular anomalies: A complex case report 149
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease 148
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 147
About the physiopathological mechanism of statin myopathy: evidence of a diffuse reduction of CoQ10 levels in skeletal muscle. 147
Intracranial aneurysm management in patients with late-onset Pompe disease (LOPD) 147
Totale 18.460
Salva come PNG Salva come JPEG
Categoria #
all - tutte 188.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.591 0 330 27 133 139 40 241 118 58 203 319 983
2022/20236.287 551 522 300 410 416 587 88 347 2.811 23 168 64
2023/20241.760 137 246 137 138 123 358 22 173 14 152 48 212
2024/20258.656 140 74 135 528 396 303 229 1.596 2.181 477 959 1.638
2025/202625.386 1.138 1.790 2.238 1.843 1.965 5.185 3.045 2.956 3.053 1.140 508 525
2026/20272.378 993 1.385 0 0 0 0 0 0 0 0 0 0
Totale 53.465